Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Omission of axillary lymph node dissection reduces arm morbidity without compromising survival in select breast cancer cases

ASCO 2026

29 May - 2 Jun 2026

Published: 30 May 2026

Views: 97

Rating:

Save

Dr Jana de Boniface - Capio St. Göran's Hospital, Stockholm, Sweden

Dr Jana de Boniface talks to ecancer at ASCO 2026 on the final results of the SENOMAC trial in patients with clinically node-negative breast cancer and one to two sentinel lymph node macrometastases.

The study found that omission of completion axillary lymph node dissection after a positive sentinel lymph node biopsy is oncologically safe and mitigates postoperative patient-reported arm-related

Related Videos

From lived experience to informed choice in breast cancer reconstruction

Louise McKenna-Mayes - Co-Founder, TONIBOBANDLOU CIC

From lived experience to informed choice in breast cancer reconstruction ( Louise McKenna-Mayes - Co-Founder, TONIBOBANDLOU CIC )

Omitting sentinel lymph node biopsy is safe in early HR-positive, HER2-negative...

Prof Marjolein Smidt - Maastricht University Medical Center, Maastricht...

Omitting sentinel lymph node biopsy is safe in early HR-positive, HER2-negative breast cancer after 5 years ( Prof Marjolein Smidt - Maastricht University Medical Center, Maastricht, Netherlands )

Sacituzumab govitecan improves PFS in first-line metastatic TNBC patients...

Dr Javier C Cortés - Hospital Ruber Internacional, Madrid Spain

Sacituzumab govitecan improves PFS in first-line metastatic TNBC patients unable to receive PD-(L)1 inhibitors ( Dr Javier C Cortés - Hospital Ruber Internacional, Madrid Spain )

Breast cancer survivorship

Dr Luzia Travado, Dr Christina Signorelli and Dr Beverley Lim Høeg

Breast cancer survivorship ( Dr Luzia Travado, Dr Christina Signorelli and Dr Beverley Lim Høeg )

SIOG 2024: Updates in medical oncology

Dr Capucine Baldini - Gustave Roussy, Villejuif, France

SIOG 2024: Updates in medical oncology ( Dr Capucine Baldini - Gustave Roussy, Villejuif, France )

ASCO GU 2025: Latest updates in mRCC

Dr Bradley McGregor, Dr Stephanie Berg, Prof Viktor Grünwald and Prof Roberto...

ASCO GU 2025: Latest updates in mRCC ( Dr Bradley McGregor, Dr Stephanie Berg, Prof Viktor Grünwald and Prof Roberto Iacovelli )

Targeted therapies associated with increased risk for and incidence of...

Dr James Martin - Cleveland Clinic, Cleveland, USA

Targeted therapies associated with increased risk for and incidence of thrombosis in the treatment of breast cancer ( Dr James Martin - Cleveland Clinic, Cleveland, USA )

The use of IORT at L'Hospitalet de Llobregat

Dr Evelyn Martínez Pérez - Catalan Institute of Oncology, Barcelona, Spain

The use of IORT at L'Hospitalet de Llobregat ( Dr Evelyn Martínez Pérez - Catalan Institute of Oncology, Barcelona, Spain )

Understanding intraoperative radiation therapy for early stage breast cancer

Dr Jana Fox - Montefiore Medical Center, New York,USA

Understanding intraoperative radiation therapy for early stage breast cancer ( Dr Jana Fox - Montefiore Medical Center, New York,USA )

More from ecancer